SOLENO THERAPEUTICS INC Net Cash Provided by (Used in) Financing Activities in USD from 2014 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Soleno Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2014 to Q1 2025.
  • Soleno Therapeutics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $3.22M, a 243% increase year-over-year.
  • Soleno Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $213M, a 18.3% increase from 2023.
  • Soleno Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $180M, a 1177% increase from 2022.
  • Soleno Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $14.1M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

SOLENO THERAPEUTICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $3.22M +$2.28M +243% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $938K +$938K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $0 -$14M -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $14M +$14.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$125K -$121K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 -$4K* Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2018 $288K -$9.71M -97.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q1 2017 $10M +$5M +100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $5M +$1.62M +47.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q1 2015 $3.38M Jan 1, 2015 Mar 31, 2015 10-Q 2016-08-09

SOLENO THERAPEUTICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $213M +$33M +18.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $180M +$166M +1177% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $14.1M +$14.2M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 -$128K -$53.9M -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $53.7M +$39.2M +271% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $14.5M -$3.35M -18.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-03
2018 $17.8M -$6.34M -26.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 $24.2M +$13.4M +124% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-20
2016 $10.8M +$1.61M +17.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $9.16M -$2.05M -18.3% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 $11.2M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.